(Reuters) – The U.S. health regulator said on Thursday the current emergency use authorization (EUA) for Pfizer’s COVID-19 antiviral pill for high-risk adolescents will continue to remain in effect even if it receives full approval for use in some adults.
Latest posts by Crypto Editor (see all)